T. Schlesinger, “Investigator Global assessment (IGA) of Actinic Keratosis (AK) among patients administered tirbanibulin in real-world community practices across the U.S., and clinician likelihood to consider tirbanibulin again for future AK treatments (PROAK Study)”, J of Skin, vol. 7, no. 2, p. s162, Mar. 2023.